Morgan Stanley Downgrades Merck (MRK) to Underweight
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $115.48 +1.41%
Rating Summary:
23 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
23 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Morgan Stanley downgraded Merck (NYSE: MRK) from Equalweight to Underweight.
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday.
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck's tulisokibart meets Phase 3 endpoints in ulcerative colitis trial
- Morgan Stanley Downgrades Cleveland-Cliffs (CLF) to Equalweight
- Canaccord Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
